We have located links that may give you full text access.
The significance of natural killer activity in the resistance of allogeneic hosts to the embryonal carcinoma cell line F9.
American Journal of Reproductive Immunology : AJRI 1982 December
A number of mouse strains of known F9 resistance phenotype have been tested for their in vitro natural killer activity against both F9 and YAC target cells. The pattern of in vitro natural killer activity observed does not correlate with the pattern of in vivo F9 resistance. The relative efficiencies of in vitro lysis of the F9 and YAC targets by endogenous natural killer effectors from the 129/Sv, SJL/J, C57Bl/6J, and BALB/cJ strains do, however, parallel each other, even though overall levels of F9 target lysis are very low. Since cold competition experiments indicate that the embryonal carcinoma cell lines tested, F9, PCC4/Aza, and PCC3/A/1, can compete efficiently with YAC as target, this low lysis of embryonal carcinoma cells may be due to an intrinsic lysis resistance. The finding that the parietal endoderm cell line PYS-2 and the trophoectodermal cell line TDM1 also compete with YAC targets in cold competition experiments is discussed in relation to previous reports suggesting that such differentiated derivatives lack natural killer target structures.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app